• Latest Posts
In Depth 22 Nov 2023

Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment

Allgenesis says dry eye patients’ trial data ‘encouraging’

Beacon Therapeutics launches with $120M to develop gene therapies for retinal diseases

Five ophthalmology biotech companies to look out for

Cell rejuvenation for age-related diseases

Astellas eyes ophthalmology field with $5.9B Iveric Bio takeover

ADVERTISEMENT

Life Biosciences gene therapy data shows visual function restored in primates

RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy

Complement Therapeutics raises €72M for eye condition gene therapy

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

Endogena Therapeutics retinitis pigmentosa treatment gets FDA fast track designation

Active Biotech trial confirms eye treatment safety

ADVERTISEMENT